Answers are grounded in this paper and cite their sources.
Preclinical study demonstrates glutathione-functionalized selenium nanoparticles suppress colorectal cancer cell growth via mitochondrial dysfunction, indicating potential as an antitumor agent.
Glutathione functionalization may improve the physicochemical and biological performance of selenium nanoparticles; however, the effects of glutathione-functionalized selenium nanoparticles (GSH-SeNPs) on colorectal cancer (CRC) cells remain insufficiently defined. In this study, GSH-SeNPs were synthesized and characterized, and their short-term in vivo tolerability was preliminarily assessed in male mice and their biological effects in CRC cells were evaluated. In a 14-day preliminary tolerability assessment in male ICR mice ( n = 6 per group), repeated oral administration of GSH-SeNPs at doses up to 2 mg/kg produced no overt changes in body weight, relative organ weights, serum hepatic and renal biochemical indices, exploratory reproductive endocrine parameters, or tissue histology. In RKO and SW480 cells, GSH-SeNPs suppressed proliferation, migration, invasion, and adhesion, altered cell-cycle distribution, and increased apoptosis. Transcriptomic and metabolomic analyses in RKO cells revealed broad mitochondria-related, stress-response, and metabolic alterations, with integrated analysis highlighting mitophagy-related processes. GSH-SeNPs increased intracellular reactive oxygen species accumulation, reduced MitoTracker fluorescence, and decreased mitochondrial membrane potential in both cell lines. In RKO cells, GSH-SeNPs further reduced basal respiration, ATP-linked respiration, maximal respiration, spare respiratory capacity, and intracellular ATP levels, accompanied by mitochondrial ultrastructural injury. Increased mitochondrial PINK1 and Parkin protein levels and the LC3B-II/LC3B-I ratio, together with reduced TOMM20 expression, were consistent with alterations in PINK1/Parkin-associated mitophagy-related signaling. Collectively, these findings indicate that GSH-SeNPs suppress malignant phenotypes in CRC cells in association with mitochondrial dysfunction and alterations in mitophagy-related signaling. These results provide a basis for further investigation, although the absence of non-functionalized SeNP and free GSH controls and the exploratory nature of the cross-omics correlation analysis should be considered when interpreting the mechanistic findings.
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: